SCHEMBL8132011

SCHEMBL8132011

CCOC(=O)c1c(CCl)nc2cc(OC)c(OC)cc2c1-c1ccc(OC)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.60
▸ KDM4E B2RXH2 3/20 0.60
▸ GAA P10253 2/20 0.55
▸ POLB P06746 1/20 0.55
▸ ALDH1A1 P00352 4/20 0.48
▸ SMN1; SMN2 Q16637 4/20 0.48
▸ SLC10A2 Q12908 2/20 0.47
▸ PDGFRB P09619 1/20 0.43
▸ PDGFRA P16234 1/20 0.43
▸ MEN1 O00255 4/20 0.43
▸ KMT2A Q03164 4/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ MAPK10 P53779 1/20 0.43
▸ HPGD P15428 1/20 0.42
▸ TP53 P04637 2/20 0.42
▸ NPC1 O15118 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8884141 0.92 MAPT (0.60) MAPTKDM4EGAAPOLBALDH1A1
SCHEMBL8883731 0.91 MAPT (0.59) MAPTKDM4EGAAPOLBALDH1A1
SCHEMBL7824433 0.91 KDM4E (0.58) MAPTKDM4EGAAPOLBALDH1A1
SCHEMBL8884728 0.88 KDM4E (0.55) MAPTKDM4EGAAPOLBALDH1A1
SCHEMBL9044254 0.87 KDM4E (0.54) MAPTKDM4EGAAALDH1A1SMN1; SMN2
SCHEMBL8886500 0.87 GAA (0.52) MAPTKDM4EGAAPOLBALDH1A1
SCHEMBL8137949 0.87 KDM4E (0.54) MAPTKDM4EGAAALDH1A1SMN1; SMN2
SCHEMBL7820772 0.85 GAA (0.50) MAPTKDM4EGAAPOLBALDH1A1
SCHEMBL7820569 0.84 KDM4E (0.52) MAPTKDM4EGAAALDH1A1SMN1; SMN2
SCHEMBL8121588 0.84 SLC10A2 (0.53) MAPTKDM4EGAAPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0634169-B1 Quinoline or quinazoline derivatives and their use in the manufacture of a medicament for the treatment of osteoporosis TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2000-01-05 — — EP disclosed
US-5852039-A Pharmaceutical composition containing quinoline or quinazoline derivatives TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-12-22 — — US disclosed
US-5719157-A OSTEOPOROSIS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-02-17 — — US disclosed
US-5650410-A ANTIINFLAMMATORY AGENTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1997-07-22 — — US disclosed
EP-0634169-A1 Pharmaceutical composition containing quinoline or quinazoline derivatives TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-01-18 — — EP disclosed
Send feedback